The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2017
Filed:
Nov. 11, 2016
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Haolun Jin, Foster City, CA (US);
Scott E. Lazerwith, Burlingame, CA (US);
Hyung-Jung Pyun, Fremont, CA (US);
Elizabeth M. Bacon, Burlingame, CA (US);
Philip Anthony Morganelli, Oakland, CA (US);
Mingzhe Ji, Union City, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5365 (2006.01); C07D 413/14 (2006.01); C07D 498/14 (2006.01); A61K 45/06 (2006.01); A61K 31/537 (2006.01); A61K 31/553 (2006.01);
U.S. Cl.
CPC ...
C07D 498/14 (2013.01); A61K 31/537 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01);
Abstract
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R, X, W, Y, Y, Z, and Zare as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.